Paul D. Wright

3.0k total citations
15 papers, 256 citations indexed

About

Paul D. Wright is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Paul D. Wright has authored 15 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Paul D. Wright's work include Ion channel regulation and function (7 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Paul D. Wright is often cited by papers focused on Ion channel regulation and function (7 papers), Cardiac electrophysiology and arrhythmias (4 papers) and Amyotrophic Lateral Sclerosis Research (3 papers). Paul D. Wright collaborates with scholars based in United Kingdom, United States and Italy. Paul D. Wright's co-authors include Alistair Mathie, Emma L. Veale, Toby Kent, Paul J. Groot‐Kormelink, Martin Gosling, Catherine Kettleborough, Tobias von der Haar, Mick F. Tuite, Jeff Jerman and M. Zameel Cader and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Pain.

In The Last Decade

Paul D. Wright

14 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul D. Wright United Kingdom	10	159	61	58	45	34	15	256
Nagisa Matsumoto Japan	8	159 1.0×	91 1.5×	93 1.6×	88 2.0×	14 0.4×	9	331
Giorgia Scarpellino Italy	11	140 0.9×	54 0.9×	86 1.5×	114 2.5×	34 1.0×	27	350
Nguyen Huu Tu United States	11	113 0.7×	113 1.9×	77 1.3×	31 0.7×	9 0.3×	21	430
Val Millar United Kingdom	7	152 1.0×	99 1.6×	91 1.6×	12 0.3×	30 0.9×	12	266
Ronnie Blazev Australia	10	193 1.2×	73 1.2×	36 0.6×	11 0.2×	48 1.4×	22	288
Marine Christin France	5	223 1.4×	179 2.9×	101 1.7×	80 1.8×	24 0.7×	5	386
Madina Makhmutova United States	7	215 1.4×	84 1.4×	42 0.7×	9 0.2×	10 0.3×	11	400
Aida Calderón‐Rivera United States	10	175 1.1×	97 1.6×	95 1.6×	14 0.3×	41 1.2×	23	245
N. A. Hayes United Kingdom	10	107 0.7×	146 2.4×	81 1.4×	25 0.6×	18 0.5×	14	363

Countries citing papers authored by Paul D. Wright

Since Specialization

Citations

This map shows the geographic impact of Paul D. Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D. Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D. Wright more than expected).

Fields of papers citing papers by Paul D. Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D. Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D. Wright. The network helps show where Paul D. Wright may publish in the future.

Co-authorship network of co-authors of Paul D. Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D. Wright. A scholar is included among the top collaborators of Paul D. Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D. Wright. Paul D. Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lovejoy, Christopher, et al.. (2025). Examining iPSC derived motor neuron variability and genome stability monitoring as a solution. Scientific Reports. 15(1). 39670–39670.

Higham, James P., Farah Barakat, Eva Wozniak, et al.. (2024). Transcriptomic profiling reveals a pronociceptive role for angiotensin II in inflammatory bowel disease. Pain. 165(7). 1592–1604. 10 indexed citations

Veale, Emma L., et al.. (2021). Aprepitant is a novel, selective activator of the K2P channel TRAAK. Biochemical and Biophysical Research Communications. 588. 41–46. 4 indexed citations

Large, Jonathan M., et al.. (2020). A “Target Class” Screen to Identify Activators of Two-Pore Domain Potassium (K2P) Channels. SLAS DISCOVERY. 26(3). 428–438. 5 indexed citations

Mathie, Alistair, et al.. (2020). Two-Pore Domain Potassium Channels as Drug Targets: Anesthesia and Beyond. The Annual Review of Pharmacology and Toxicology. 61(1). 401–420. 40 indexed citations

Wright, Paul D., et al.. (2019). Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2. Biochemical and Biophysical Research Communications. 520(1). 35–40. 16 indexed citations

Wright, Paul D., Emma L. Veale, Jonathan M. Large, et al.. (2017). Terbinafine is a novel and selective activator of the two-pore domain potassium channel TASK3. Biochemical and Biophysical Research Communications. 493(1). 444–450. 24 indexed citations

Mpamhanga, Chido, Laura De Conti, Paul D. Wright, et al.. (2017). [P1–131]: PHENOTYPIC HIGH‐CONTENT SCREEN MEASURING CLEARANCE OF TDP ‐ 43 AGGREGATES. Alzheimer s & Dementia. 13(7S_Part_5). 1 indexed citations

Wright, Paul D., Nathalie Bouloc, Timothy Dale, et al.. (2015). A High-Throughput Electrophysiology Assay Identifies Inhibitors of the Inwardly Rectifying Potassium Channel Kir7.1. SLAS DISCOVERY. 20(6). 739–747. 8 indexed citations

10.

Wright, Paul D., et al.. (2013). Cloxyquin (5-chloroquinolin-8-ol) is an activator of the two-pore domain potassium channel TRESK. Biochemical and Biophysical Research Communications. 441(2). 463–468. 32 indexed citations

11.

Wright, Paul D.. (2012). A high-throughput screen to identify inhibitors of SOD1 transcription. Frontiers in Bioscience-Elite. E4(8). 2701–2708. 15 indexed citations

12.

Groot‐Kormelink, Paul J., et al.. (2012). Quantitative GPCR and ion channel transcriptomics in primary alveolar macrophages and macrophage surrogates. BMC Immunology. 13(1). 57–57. 43 indexed citations

13.

Wright, Paul D., Mickey Huang, Alexandra Weiss, et al.. (2010). Screening for inhibitors of the SOD1 gene promoter: Pyrimethamine does not reduce SOD1 levels in cell and animal models. Neuroscience Letters. 482(3). 188–192. 10 indexed citations

14.

Haar, Tobias von der, et al.. (2007). Development of a Novel Yeast Cell-Based System for Studying the Aggregation of Alzheimer’s Disease-Associated Aβ Peptides in vivo. Neurodegenerative Diseases. 4(2-3). 136–147. 37 indexed citations

15.

Marks, S. C., et al.. (1986). Bone particles from osteopetrotic mice not cured by bone marrow transplants are resorbed in normal littermates. Bone. 7(6). 473–478. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact